286 related articles for article (PubMed ID: 14534534)
1. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor).
Tolg C; Poon R; Fodde R; Turley EA; Alman BA
Oncogene; 2003 Oct; 22(44):6873-82. PubMed ID: 14534534
[TBL] [Abstract][Full Text] [Related]
2. IFN-{beta} signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors.
Tjandra SS; Hsu C; Goh YI; Gurung A; Poon R; Nadesan P; Alman BA
Cancer Res; 2007 Aug; 67(15):7124-31. PubMed ID: 17671179
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 (PAI-1) modifies the formation of aggressive fibromatosis (desmoid tumor).
Fen Li C; Kandel C; Baliko F; Nadesan P; Brünner N; Alman BA
Oncogene; 2005 Feb; 24(9):1615-24. PubMed ID: 15674349
[TBL] [Abstract][Full Text] [Related]
4. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
[TBL] [Abstract][Full Text] [Related]
5. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).
Lips DJ; Barker N; Clevers H; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):3-10. PubMed ID: 18722078
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor).
Poon R; Smits R; Li C; Jagmohan-Changur S; Kong M; Cheon S; Yu C; Fodde R; Alman BA
Oncogene; 2001 Jan; 20(4):451-60. PubMed ID: 11313976
[TBL] [Abstract][Full Text] [Related]
7. [Abnormalities of chromosome 8, APC and beta-catenin genes in aggressive fibromatosis].
Yang JL; Wang J; Zhou XY; Zhu XZ
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):116-20. PubMed ID: 18646694
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
Kohler EM; Chandra SH; Behrens J; Schneikert J
Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
[TBL] [Abstract][Full Text] [Related]
9. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
[TBL] [Abstract][Full Text] [Related]
10. Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells.
Wu C; Amini-Nik S; Nadesan P; Stanford WL; Alman BA
Cancer Res; 2010 Oct; 70(19):7690-8. PubMed ID: 20841474
[TBL] [Abstract][Full Text] [Related]
11. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
[TBL] [Abstract][Full Text] [Related]
12. [Agressive fibromatosis: genetic and biological correlations].
Hlavatá Z; Porsok S
Klin Onkol; 2012; 25(2):85-90. PubMed ID: 22533881
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive genetic and endoscopic evaluation may be necessary to distinguish sporadic versus familial adenomatous polyposis-associated abdominal desmoid tumors.
Bandipalliam P; Balmana J; Syngal S
Surgery; 2004 Jun; 135(6):683-9. PubMed ID: 15179376
[TBL] [Abstract][Full Text] [Related]
14. Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis.
Jilong Y; Jian W; Xiaoyan Z; Xiaoqiu L; Xiongzeng Z
Pathology; 2007 Jun; 39(3):319-25. PubMed ID: 17558858
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
[TBL] [Abstract][Full Text] [Related]
16. Aggressive fibromatosis (desmoid tumors): definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background.
Ferenc T; Sygut J; Kopczyński J; Mayer M; Latos-Bieleńska A; Dziki A; Kulig A
Pol J Pathol; 2006; 57(1):5-15. PubMed ID: 16739877
[TBL] [Abstract][Full Text] [Related]
17. APC mutations in FAP-associated desmoid tumours are non-random but not 'just right'.
Latchford A; Volikos E; Johnson V; Rogers P; Suraweera N; Tomlinson I; Phillips R; Silver A
Hum Mol Genet; 2007 Jan; 16(1):78-82. PubMed ID: 17135276
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis.
Kong Y; Poon R; Nadesan P; Di Muccio T; Fodde R; Khokha R; Alman BA
Cancer Res; 2004 Aug; 64(16):5795-803. PubMed ID: 15313922
[TBL] [Abstract][Full Text] [Related]
19. Analysis of APC, alpha-, beta-catenins, and N-cadherin protein expression in aggressive fibromatosis (desmoid tumor).
Ferenc T; Wroński JW; Kopczyński J; Kulig A; Sidor M; Stalińska L; Dziki A; Sygut J
Pathol Res Pract; 2009; 205(5):311-24. PubMed ID: 19124205
[TBL] [Abstract][Full Text] [Related]
20. Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour).
Tejpar S; Li C; Yu C; Poon R; Denys H; Sciot R; Van Cutsem E; Cassiman JJ; Alman BA
Br J Cancer; 2001 Jul; 85(1):98-101. PubMed ID: 11437409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]